NBN EN ISO 10993-6 : 2009
Current
The latest, up-to-date edition.
BIOLOGICAL EVALUATION OF MEDICAL DEVICES - PART 6: TESTS FOR LOCAL EFFECTS AFTER IMPLANTATION
12-01-2013
Foreword
1 Scope
2 Normative references
3 Terms and definitions
4 Common provisions for implantation test methods
4.1 General
4.2 Preparation of specimens for implantation
5 Test methods, general aspects
5.1 Tissue and implantation site
5.2 Animals
5.3 Test periods
5.4 Surgery and testing conditions
5.5 Evaluation
6 Test report
Annex A (informative) - General considerations regarding
implantation periods and tissue responses to
degradable/resorbable materials
Annex B (normative) - Test methods for implantation in
subcutaneous tissue
Annex C (normative) - Test method for implantation in muscle
Annex D (normative) - Test method for implantation in bone
Annex E (informative) - Examples of evaluation of local
biological effects after implantation
Annex ZA (informative) - Clauses of this International Standard
addressing essential requirements or other provisions
of EU Directives 90/385/EEC for Active Implantable
Medical Devices and 93/42/EEC for Medical Devices
Bibliography
Describes test methods for the assessment of the local effects after implantation of biomaterials intended for use in medical devices.
DevelopmentNote |
Supersedes NBN EN 30993-6. (11/2007)
|
DocumentType |
Standard
|
PublisherName |
Belgian Standards
|
Status |
Current
|
Standards | Relationship |
DIN EN ISO 10993-6:2009-08 | Identical |
I.S. EN ISO 10993-6:2016 | Identical |
DIN EN ISO 10993-6:2017-09 | Identical |
UNE-EN ISO 10993-6:2017 | Identical |
EN ISO 10993-6:2016 | Identical |
BS EN ISO 10993-6:2016 | Identical |
UNI EN ISO 10993-6 : 2009 | Identical |
SN EN ISO 10993-6 : 2017 | Identical |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.